Sanofi Outlines Plans To Establish Lantus As Leading Worldwide Anti-Diabetic

Sanofi-Aventis aims to establish its long-acting insulin Lantus (insulin glargine injection) as the leading anti-diabetic worldwide by marketing it for combination use as well as a stand-alone product